Advanced Glycation End Products and Cardiovascular Disease

被引:57
|
作者
Peppa, Melpomeni [1 ]
Raptis, Sotirios A. [1 ]
机构
[1] Attikon Univ Hosp, Res Inst & Diabet Ctr & Hel lenic Natl Diabet Ctr, Dept Internal Medicine Propaedeut 2, Endocrine Unit, Athens, Greece
关键词
Cardiovascular disease; Atherosclerosis; Oxidative stress; Inflammation; Arterial stiffening; Endothelium; Diet; Advanced glycation end products; AGEs; AGE-receptors; AGE-inhibitors; AGE-breakers;
D O I
10.2174/157339908784220732
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Advanced glycation end products [AGEs] seem to play an important role for the development and/or progression of CVD mainly through induction of oxidative stress and inflammation. AGEs are a heterogenous group of molecules formed by the nonenzymatic reaction of reducing sugars with amino acids of proteins, lipids and nucleic acids. Recent studies suggest that in addition to those endogenously formed, diet constitutes an important exogenous source of AGEs. Diet-derived AGEs contribute to the whole body AGE pool and the AGE-related pathology. Recent in vitro and in vivo studies revealed significant correlations between diet-derived AGEs and several risk factors and/ or markers of CVD, suggesting the dietary AGEs restriction as a promising therapeutic intervention.
引用
收藏
页码:92 / 100
页数:9
相关论文
共 50 条
  • [21] Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study
    Jinluan Chen
    Banafsheh Arshi
    Komal Waqas
    Tianqi Lu
    Daniel Bos
    M. Arfan Ikram
    André G. Uitterlinden
    Maryam Kavousi
    M. Carola Zillikens
    Cardiovascular Diabetology, 22
  • [22] ADVANCED GLYCATION END PRODUCTS (AGES), CARDIOVASCULAR DISEASE AND CKD-MBD IN HEMODIALYSIS PATIENTS
    Nogueira, Luiz C. F.
    Borges, Cynthia M.
    Franca, Renata A.
    Salani, Talita G.
    Barcelos, Viviane M.
    de Oliveira, Rodrigo B.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [23] Advanced Glycation End Products Are Associated with Diabetes Status and Physical Functions in Patients with Cardiovascular Disease
    Hirai, Tomoya
    Fujiyoshi, Kazuhiro
    Yamada, Satoru
    Matsumoto, Takuya
    Kikuchi, Junko
    Ishida, Kohki
    Ishida, Miwa
    Yamaoka-Tojo, Minako
    Inomata, Takayuki
    Shigeta, Kyo
    Tojo, Taiki
    NUTRIENTS, 2022, 14 (15)
  • [24] Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
    Takanobu Takata
    Akiko Sakasai-Sakai
    Tadashi Ueda
    Masayoshi Takeuchi
    Scientific Reports, 9
  • [25] Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study
    Chen, Jinluan
    Arshi, Banafsheh
    Waqas, Komal
    Lu, Tianqi
    Bos, Daniel
    Ikram, M. Arfan
    Uitterlinden, Andre G.
    Kavousi, Maryam
    Zillikens, M. Carola
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [26] Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
    Takata, Takanobu
    Sakasai-Sakai, Akiko
    Ueda, Tadashi
    Takeuchi, Masayoshi
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [27] Association between fingertip-measured advanced glycation end products and cardiovascular events in outpatients with cardiovascular disease
    Tomoya Hirai
    Kazuhiro Fujiyoshi
    Satoru Yamada
    Takuya Matsumoto
    Junko Kikuchi
    Kohki Ishida
    Miwa Ishida
    Kyo Shigeta
    Taiki Tojo
    Cardiovascular Diabetology, 22
  • [28] Association between fingertip-measured advanced glycation end products and cardiovascular events in outpatients with cardiovascular disease
    Hirai, Tomoya
    Fujiyoshi, Kazuhiro
    Yamada, Satoru
    Matsumoto, Takuya
    Kikuchi, Junko
    Ishida, Kohki
    Ishida, Miwa
    Shigeta, Kyo
    Tojo, Taiki
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [29] Cardiovascular risk in patients with end-stage renal disease: A potential role for advanced glycation end products
    Wang, YJ
    Marshall, SM
    Thompson, MG
    Hoenich, NA
    CARDIOVASCULAR DISORDERS IN HEMODIALYSIS, 2005, 149 : 168 - 174
  • [30] Advanced glycation end products are associated with cardiovascular risk in the Mexican population
    Robles-Rivera, Karina
    Rivera-Paredez, Berenice
    Quezada-Sanchez, Amado D.
    Velazquez-Cruz, Rafael
    Salmeron, Jorge
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (04) : 826 - 834